» Articles » PMID: 38438738

Genetic Variants in M5C Modification Genes Are Associated with Survival of Patients with HBV-related Hepatocellular Carcinoma

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2024 Mar 4
PMID 38438738
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high mortality rate. The 5-methylcytosine (m5C), a type of RNA modification, plays crucial regulatory roles in HCC carcinogenesis, metastasis, and prognosis. However, a few studies have investigated the effect of genetic variants in m5C modification genes on survival of patients with hepatitis B virus (HBV)-related HCC. In the present study, we evaluated associations between 144 SNPs in 15 m5C modification genes and overall survival (OS) in 866 patients with the HBV-related HCC. Expression quantitative trait loci (eQTL) analysis and differential expression analysis were conducted to investigate biological mechanisms. As a result, we identified that two SNPs (NSUN7 rs2437325 A > G and TRDMT1 rs34434809 G > C) were significantly associated with HBV-related HCC OS with adjusted allelic hazards ratios of 1.25 (95% confidence interval = 1.05-1.48 and P = 0.011) and 1.19 (1.02-1.38 and P = 0.027), respectively, with a trend of combined risk genotypes (P < 0.001). Moreover, the results of eQTL analyses showed that both NSUN7 rs2437325 G and TRDMT1 rs34434809 C alleles were associated with a reduced mRNA expression level in 208 normal liver tissues (P = 0.007 and P < 0.001, respectively). Taken together, genetic variants in the m5C modification genes may be potential prognostic biomarkers of HBV-related HCC after hepatectomy, likely through mediating the mRNA expression of corresponding genes.

Citing Articles

mC RNA methylation: a potential mechanism for infectious Alzheimer's disease.

Teng S, Han C, Zhou J, He Z, Qian W Front Cell Dev Biol. 2024; 12:1440143.

PMID: 39175875 PMC: 11338875. DOI: 10.3389/fcell.2024.1440143.

References
1.
Aguilo F, Li S, Balasubramaniyan N, Sancho A, Benko S, Zhang F . Deposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1α. Cell Rep. 2016; 14(3):479-492. PMC: 4731243. DOI: 10.1016/j.celrep.2015.12.043. View

2.
Bohnsack K, Hobartner C, Bohnsack M . Eukaryotic 5-methylcytosine (m⁵C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease. Genes (Basel). 2019; 10(2). PMC: 6409601. DOI: 10.3390/genes10020102. View

3.
Chang J, Lin L, Zhou C, Zhang X, Yang T, Wu H . Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children. J Cell Mol Med. 2023; 27(15):2239-2248. PMC: 10399530. DOI: 10.1111/jcmm.17820. View

4.
Chen H, Yang H, Zhu X, Yadav T, Ouyang J, Truesdell S . mC modification of mRNA serves a DNA damage code to promote homologous recombination. Nat Commun. 2020; 11(1):2834. PMC: 7275041. DOI: 10.1038/s41467-020-16722-7. View

5.
Elhardt W, Shanmugam R, Jurkowski T, Jeltsch A . Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties. Biochimie. 2015; 112:66-72. DOI: 10.1016/j.biochi.2015.02.022. View